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Abstract
Background: It has been proposed that sildenafil citrate can increase ocular blood flow, and that this property can
be used to treat ocular disorders that involve reflex vasoconstriction. This study therefore proposes to ascertain the
vasodilator effect of the drug on retrobulbar circulation in healthy rabbits. For this matter rabbits treated with
sildenafil citrate or saline solution had their intraocular pressure (IOP), mean arterial pressure (MAP), ocular perfusion
pressure (OPP) and color Doppler imaging of the external ophthalmic artery measured prior to treatment and on
days one (moment M1), seven (when M2), fourteen (moment M3), twenty-one (moment M4), and thirty (moment M5)
of treatment.
Results: The MAP and OPP values of treated group were lower than those of control group at all times, and the mean
values differed statistically at moments M1 (S = 71.52 mmHg, C = 84.76 mmHg, p = 0.0356) and M5 (S = 71.38 mmHg,
C = 85.52 mmHg, p = 0.0252). The IOP and color Doppler values of the external ophthalmic artery did not differ
between tested groups.
Conclusions: The dose of 10 mg of sildenafil citrate administered to healthy rabbits causes systemic vasodilation and
consequently lower values of MAP and OPP. However, it does not induce changes in IOP and retrobulbar hemodynamics
identifiable by color Doppler assessment of the external ophthalmic artery.
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Background
Sildenafil citrate was the first phosphodiesterase type 5
(PDE-5) inhibitor to be approved for treatment of erect-
ile dysfunction, and has become one of the world’s most
widely prescribed drugs. This drug inhibits PDE5, en-
zyme that hydrolyzes cyclic guanosine monophosphate
(cGMP), regulating the circulating levels of cGMP, which
in turn causes the corpus cavernosum muscles to relax
and local blood flow to increase [1, 2].
PDE5, however, is present not only in the corpus cav-
ernosum penis but also in the cells of the smooth
muscle of peripheral arteries and veins, and in the pul-
monary and coronary circulation, platelets and endothe-
lial cells of blood vessels [3]. Therefore, PDE5 inhibitor
drugs can cause systemic hemodynamic changes [2].
Although the drug is widely used for treatment of erect-
ile dysfunction, some users exhibited ocular side effects
such as blurred vision and increased sensitivity to light.
These symptoms are associated with cross-inhibition of
the drug with phosphodiesterase type 6 that is present in
the retina, which participates in the regulation of the
phototransduction mechanism. However, no consensus
has yet been reached about the effects of sildenafil citrate
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on retinal and retrobulbar blood flow upon inhibiting the
PDE5 contained in the walls of the vessels in these regions
[2].
According to Silva et al. [4], identifying and quantifying
the vasodilator activity in retrobulbar circulation resulting
from the action of sildenafil citrate can provide important
clinical information, especially for patients suffering from
ocular reflex vasoconstriction conditions, such as retinal
hypertension observed in patients with kidney failure. Ac-
cording to this author, chronic hypertension leads to
continuous compensatory vasoconstriction of retinal arte-
rioles, inducing ischemia and retinal degeneration, which
impairs the functioning of this tissue.
Considering the potential of sildenafil citrate for treat-
ment of ocular conditions with reflex vasoconstriction,
the purpose of this study was to determine whether the
drug has a vasodilator effect on retrobulbar circulation
in healthy rabbits, based on an assessment of ocular
perfusion pressure and on color Doppler imaging of the
external ophthalmic artery.
Methods
Animals: care, husbandry, and general experimental
procedure
The experiment was based on the recommendations of
the Association for Research in Vision and Ophthalmol-
ogy (ARVO) and Animal Research: Reporting of in Vivo
Experiment (ARRIVE) guidelines. The study was also
submitted under Proposal No. 027/12, and was approved
by the Ethics Committee on Animal Use of the Federal
University of Goiás (UFG).
The study involved 14 healthy adult male New Zealand
white rabbits weighing on average 2.5 kg. The sample
size was based on the number required to obtain reliable
statistical results. The animals were acquired from a
local supplier (MH Cunicultura Coelho Forte), located at
Rodovia Bela Vista-Hidrolândia Km 9, Bela Vista de
Goiás, Goiás – Brazil. The animals’ eyes and overall
health were considered normal after a clinical examin-
ation done by an experienced veterinarian, as recom-
mended by TALIERI et al. [5]. The animals were kept in
a bioterium, under veterinary supervision, and trans-
ported to the laboratory when needed for the experi-
ments. In the bioterium, the rabbits were housed in
individual cages with free access to food and water, and
the local temperature was kept at 24 ± 1 °C.
The rabbits were divided into two groups of seven ani-
mals each (n = 7), a control group (C) and a treatment
group (S). Group (C) was given 1.5 mL of saline orally,
while group (S) was given 10 mg of sildenafil citrate
(Viagra®, Pfizer, Guarulhos, SP) orally. Both groups were
treated at 24-h intervals for 30 consecutive days.
The experimental protocol followed the sequence: (1)
oral administration of the vasodilator sildenafil, (2)
measurement of intraocular pressure (IOP), (3) measure-
ment of mean arterial pressure (MAP), and (4) color
Doppler imaging of the external ophthalmic artery.
Because sildenafil citrate was administered orally, a 45 to
60 min wait time was allowed between ingestion of the
drug and the subsequent steps of the protocol.
The evaluations were performed weekly, as follows:
Day one - moment 1 (M1), Day seven - moment 2 (M2),
Day fourteen - moment 3 (M3), Day twenty-one - mo-
ment 4 (M4), and day thirty - moment 5 (M5).
To measure the IOP and MAP and for the Doppler
study, the unsedated rabbits were wrapped in a towel,
leaving only the head exposed for the investigator to take
the measurements. Care was taken not to apply excessive
force in restraining the animals during these evaluations.
All the evaluations were performed in triplicate by the
same investigator, in a blind study. To reduce the period
of restraint, only the right eye of each animal was exam-
ined, thus avoiding the effects of stress on the retrobulbar
circulation and optimizing the action time of the drug.
Measurement of IOP
The intraocular pressure of rabbits was measured with a
Tono-Pen AVIA VET® applanation tonometer (Reichert®,
New York, USA). The procedure consisted in gently lift-
ing the eyelid, applying a drop of 0.5 % proparacaine
(Anestalcon®, Alcon, São Paulo, SP) on the eye, and tak-
ing a reading with the tonometer five minutes later.
Measurement of MAP
After the trichotomy and antisepsis of the dorsal surface
of the rabbits’ ears, the central artery was cannulated
with a 24G catheter (BD AngiocathTM, Becton Dickinson
Indústrias Cirúrgicas Ltda, Juiz de Fora, MG, Brazil).
The catheter was then plugged to a semi-rigid silicone
tubing system. In this system, two silicone tubes were
connected to a three-way stopcock. The free end of one
the tube was attached a catheter and the other end to a
BD sphygmomanometer (Becton, Dickinson and Com-
pany, Franklin Lakes, NJ, USA). The system was then
filled with 1 mL/1000 mL of 0.9 % heparinized saline
(Heparin, Cristália Produtos Químicos Farmaceuticos
Ltda, Itapira, SP, Brazil). The air/liquid interface was po-
sitioned at the height of the right atrium and eye, and
the mean arterial pressure was read with the sphygmo-
manometer [6].
Calculation of OPP
The ocular perfusion pressure (OPP) was determined by
subtracting the mean arterial pressure (MAP) from the
intraocular pressure (IOP), as described by KIEL &
HEUVEN [6].
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Color Doppler imaging
The color Doppler evaluation of the external ophthalmic
artery was performed using a MyLab™ 30 VET ultra-
sound system (The Esaote Group, Genoa, Italy) coupled
to a 13–18 MHz linear transducer.
Before the examination, the cornea was anesthetized
by applying one drop of 0.5 % proparacaine hydrochlor-
ide topical ophthalmic anesthetic (Anestalcon®, Alcon,
São Paulo, SP, Brazil). A layer of sterile aqueous gel was
then applied to the corneal surface, and the transducer
was gently placed in a longitudinal position, with the
position indicator facing the upper eyelid.
The sagittal image of the eyeball and optic nerve were
recorded in two-dimensional mode. The external oph-
thalmic artery was identified near the entrance of the
optic nerve by color Doppler imaging. The cursor of the
pulsed wave Doppler was then immediately positioned
over the ophthalmic artery, within the vessel lumen,
using the uniform insonation method, to record its
blood flow curve, after which the peak systolic velocity
(PSV) and end diastolic velocity (EDV) were evaluated
based on this curve. The angle was not corrected and
measurements greater than 60° were not included. The
ophthalmic artery resistance index (RI) was calculated,
automatically by the software Mylab desk, witch in based
on the Pourcelot equation (RI = PSV − EVS/ PSV), and
the curves were analyzed by the same operator (APAC),
whom marked the PSV and the EDV of three consecu-
tive curves [7].
Statistical analysis
A randomized 2 x 5 split-plot experimental design was
used, with the treatments corresponding to the plots
(with and without sildenafil citrate), the evaluation pe-
riods to the subplots (M1 - M2 - M3 - M4 - M5), and
each animal to an experimental unit.
Using R® statistical software, the data were tested for
normality by the Shapiro-Wilk test and subjected to an
analysis of variance. The means were compared by the
Tukey test, adopting a 5 % level of significance.
Results
Ocular perfusion pressure
The mean baseline IOP, MAP and OPP values were
11.85 mmHg, 80.71 mmHg and 68.85 mmHg, respect-
ively, in both groups.
In experimental conditions, the MAP and OPP values
of group (S) were lower and statistically different from
those of group (C) at moments M1 (S = 71.52 mmHg,
C = 84.76 mmHg, p = 0.0356) and M5 (S = 71.38 mmHg,
C = 85.52 mmHg, p = 0.0252). However, the IOP values
did not differ statistically during the experimental period
(Table 1).
Color Doppler imaging
Prior to treatment, the mean baseline values observed in
color Doppler study of the external ophthalmic artery of
the right eye of rabbits in both groups were 22.99 cm/s
at PSV and 12.29 cm/s at EDV and the resistance index
was 0.53. The external ophthalmic artery showed a red
flow in the color Doppler and exhibited a laminar flow
pattern with intermediate resistivity, dichroism, and the
presence of two peak systolic velocities (Fig. 1). Under
experimental conditions, however, the color Doppler
values of tested groups showed no statistical difference
(Table 2).
Discussion
In this study, it was found that sildenafil citrate reduced
mean arterial pressure in rabbits. In humans, this drug
has also been found to cause a significant reduction in
systolic and diastolic blood pressure one hour after in-
gestion [8, 9]. However, other studies found no changes
in blood pressure in humans after the administration of
Table 1 Means and standard errors of measurement of mean
arterial pressure (MAP), intraocular pressure (IOP) and ocular
perfusion pressure (OPP) of rabbits treated with 10 mg of
sildenafil citrate (sildenafil) and not treated (control) for 30 days
Moments Treatment P values
Sildenafil Control P* (T) P** (M) P*** (I)
MAP
M1 71.52 (4.32)Ab 84.76 (4,32) Aa 0.0254 0.9604 0.4547
M2 74.95 (4.32) Aa 84.85 (4.32) Aa
M3 78.71 (4.32) Aa 80.09 (4.32) Aa
M4 75.14 (4.32) Aa 78.95 (4.32) Aa
M5 71.38 (4.32) Ab 85.52 (4.32) Aa
IOP
M1 11.52 (0.79) Aa 10.66 (0.79) Aa 0.0834 0.4102 0.9989
M2 13.04 (0.79) Aa 12.04 (0.79) Aa
M3 12.24 (0.79) Aa 11.14 (0.79) Aa
M4 12.57 (0.79) Aa 11.23 (0.79) Aa
M5 12.43 (0.79) Aa 11.38 (0.79) Aa
OPP
M1 59.99 (4.52) Ab 74.09 (4.52) Aa 0,0175 0,9744 0,5525
M2 61.90 (4.52) Aa 72.81 (4.52) Aa
M3 66.47 (4.52) Aa 68.95 (4.52) Aa
M4 62.57 (4.52) Aa 67.71 (4.52) Aa
M5 58.95 (4.52) Ab 74.14 (4.52) Aa
M = moment. M1 = day one, M2 = day seven, M3 = day fourteen, M4 = day
twenty-one, M5 = day thirty
Treatment P * (T), P ** Moment (M) P *** Interaction (I)
Tukey test at a 5 % level of significance. The same letters correspond to the
same means, with upper case letters representing moments within the same
treatment and lower case letters to moments of different treatments. Values
in brackets show standard errors of the means
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this drug [10–12]. Despite the significant decrease in
MAP at moments M1 and M5, the treated animals
showed no hypotension, given that the normal blood
pressure of this species ranges from 70 mmHg to
170 mmHg [13].
As for intraocular pressure, no statistical differences
were found between the groups. Like this study, other
studies on rabbits have shown no significant increases in
IOP with the use of sildenafil citrate [14–16]. However,
sheep treated with the minimum (50 mg) and maximum
(100 mg) doses recommended for humans showed an
elevation of IOP [17]. Another study also reported in-
creased IOP in humans one hour after ingestion of the
drug, with a return to baseline values in the second hour
[9]. Other studies involving healthy humans with open
angle glaucoma did not find that the drug affected the
IOP values [8, 10, 18]. The MAP is known to have a
minimal effect on IOP, since the production of aqueous
humor depends on three phenomena, namely, ultrafiltra-
tion, active secretion and diffusion [19], and therefore
minor decreases in MAP will not change the IOP, as
noted in the study.
In this study, the ocular perfusion pressure of rabbits
was calculated based on measured MAP and IOP values.
The perfusion pressure of an organ can be defined as
the difference between its arterial and venous blood
pressure [20]. In rabbits, the mean ophthalmic arterial
pressure is similar to the MAP, while the mean ophthal-
mic venous pressure is similar to the IOP [6]. The ocular
perfusion pressure (OPP) is therefore determined
from the difference between MAP and IOP [20].
Thus, the increase in IOP or the decrease in MAP
may lower the perfusion pressure of the tissue of the
eye [21]. The animals used in this study presented
significant decreases in MAP which resulted in de-
crease in OPP, with groups (C) and (S) showing a
statistical difference at moments M1 and M5. In hu-
man patients with age-related macular degeneration,
sildenafil citrate also reduced the OPP by reducing
the MAP, associated with the maintenance of the IOP
within normal values [8].
The ophthalmic artery resistance index of rabbits did
not change in response to sildenafil citrate. Moreover, it
has been shown that the drug does not alter the resist-
ance of the ophthalmic artery in humans [22]. Another
study, however, reported increased resistance of the
ophthalmic artery one hour after the administration of
100 mg of sildenafil citrate in men with erectile dysfunc-
tion [11]. Bioequivalence studies of sildenafil citrate
done in rabbits, humans and rats showed that the distri-
bution volume in rabbits is similar to humans, however
the greater hepatic metabolism in rabbits can diminish
Fig. 1 Color Doppler image and pulsed wave flow of the external ophthalmic artery of an adult male New Zealand white rabbit treated with
10 mg of sildenafil citrate (day 15). Blood flow in the external ophthalmic artery towards the transducer shown in red and flow in the opposite
direction in blue. The external ophthalmic artery exhibited a laminar flow pattern with intermediate resistivity, dichroism, and two peak systolic
velocities (a and b). Optic nerve (white arrow)
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its bioavailability. Also, the greater renal excretion in
rabbits can diminish the half-life of sildenafil citrate in
this species [23]. Knowing that, the authors of this
paper choose to use a greater dose than the human
dose (50–100 mg/human or 0,7–1,4 mg/Kg in a 70 Kg
human) and a dose the have shown increase retinal circu-
lation in rabbits (3,5 mg/Kg or 10 mg/rabbit) in a previous
study preformed by the co-autor AVCA in 2014 [16].
Although the decrease in MAP was expected to lower
the external ophthalmic artery resistance index, this was
not observed in this study. It is believed that this result
may be due to compensatory mechanisms of self-
regulation that act on the external ophthalmic artery to
maintain the ocular infusion [11], or that sildenafil citrate
does not act on the muscles of the external ophthalmic
artery. Tissues that are sensitive to the action of sildenafil
citrate are innervated by nitric oxide-producing neurons.
Nitric oxide is a potent vasodilator that, when released,
stimulates endogenous receptors to release cGMP, a sec-
ond messenger that triggers a cascade of smooth muscle
relaxation of the vessels. The PDE5 enzyme degrades the
excess of cGMP. Sildenafil inhibits PDE5, increasing the
cGMP levels and causing vasodilation [24]. PDE5 expres-
sion has been reported in human retinal and choroidal
vasculature [12]. However, no studies were found in the
literature about the presence of PDE5 in the ophthalmic
artery of humans or in the external ophthalmic artery of
rabbits; hence, it is not possible to state whether or not
this vessel is sensitive to the action of sildenafil citrate.
Conclusions
In summary, based on the data obtained in this study, it
can be stated that a dose of 10 mg of sildenafil citrate
administered to healthy rabbits causes systemic vasodila-
tion, lowering their mean arterial pressure and ocular
perfusion pressure. However, the drug does not induce
changes in the retrobulbar hemodynamics detectable by
color Doppler imaging of the external ophthalmic artery,
nor does it alter the IOP.
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Table 2 Means and standard errors of measured peak systolic
velocity (PSV), end diastolic velocity (EDV) and resistance index
(RI) of the external ophthalmic artery of rabbits treated with
10 mg of sildenafil citrate (sildenafil) and untreated rabbits
(control) in 30 days
Moments Treatment P* Values
Sildenafil Control P* (T) P** (M) P*** (I)
PSV
M1 28.92 (1,79)Aa 28.62 (2,06)Aa
M2 32.06 (1,79)Aa 26.55 (1,79)Aa
M3 29.49 (1,79)Aa 26.30 (2,05)Aa 0.265 0.126 0.364
M4 29.26 (1,90)Aa 28.85 (1,79)Aa
M5 26.19 (1,79)Aa 25.30 (1,79)Aa
EDV
M1 14.64 (1.25)Aa 16.54 (1.44)Aa
M2 17.37 (1.25)Aa 14.05 (1.25)Aa
M3 15.19 (1.25)Aa 14.47 (1.43)Aa 0.691 0.177 0.18
M4 15.94 (1.33)Aa 15.53 (1.25)Aa
M5 13.53 (1.25)Aa 13.56 (1.25)Aa
RI
M1 0.48 (0.01)Aa 0.47 (0.02)Aa
M2 0.46 (0.01)Aa 0.46 (0.01)Aa
M3 0.49 (0.01)Aa 0.44 (0.02)Aa 0.379 0.811 0.54
M4 0.45 (0.02)Aa 0.46 (0.01)Aa
M5 0.48 (0.01)Aa 0.46 (0.01)Aa
M = moment. M1 = day one, M2 = day seven, M3 = day fourteen, M4 = day
twenty-one, M5 = day thirty
Treatment P * (T), P ** Moment (M) P *** Interaction (I)
Tukey test at a 5 % level of significance. The same letters correspond to the same
means, with upper case letters representing moments within the same treatment
and lower case ones to moments of different treatments. Values in brackets show
standard errors of the means
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